Odonate Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Odonate Therapeutics, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$12.45 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-05-03
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$12.45M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$1.77M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month |
|---|---|
| 2018-03-31 | -$12.45M 10-Q · filed 2018-05-03 |
| 2017-03-31 | -$1.77M 10-Q · filed 2018-05-03 |